Classification
- Anatomical main groupBBlood and blood-forming organs
- Therapeutic subgroupB05
- Pharmacological subgroupB05B
- Chemical subgroupB05BA
- Chemical substanceB05BA03Carbohydrates
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Canada
Health Canada · 835 registrations
- 10% Dextrose Injection USP100 MG / ML · Solution · B. Braun Medical INC
- 10% Dextrose Injection, USP10 G / 100 ML · Solution · Baxter Corporation
- 5% Dextrose Injection50 MG / ML · Solution · Fresenius Kabi Canada LTD
- 5% Dextrose Injection USP50 MG / ML · Solution · B. Braun Medical INC
United States
FDA · 345 registrations
At a glance
- ATC code
- B05BA03
- ATC group
- Blood and blood-forming organs
- Registers
- 6
- Historical lists
- 1
- Registrations
- 1,589
- With their own page
- 625
- Companies
- 156
All medicines with Dextrose
Human medicines from every register that match Dextrose by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
1,640 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Dextrose | Saudi Arabia | Authorised | Advanced Pharmaceutical Factory (Apf) | ||
| Dextrose | Saudi Arabia | Authorised | Advanced Pharmaceutical Factory (Apf) | ||
| Dextrose 25% | United States | 250MG/ML | injectable | Marketed | Hospira |
| Dextrose 50% | United States | 500MG/ML | injectable | Marketed | Intl Medication Sys |
| Dextrose 5% | United States | 50MG/ML | injectable | Not marketed | Am Regent |
| Dextrose 60% | United States | 60GM/100ML | injectable | Not marketed | B Braun |
| Dextrose Injection | Canada | 50 % / W/V | Solution | Marketed | Omega Laboratories Limited |
| Dextrose 5% in Plastic Container | United States | 50MG/ML, 5GM/100ML | injectable | Marketed | Otsuka Icu Medcl |
| Dextrose 10% in Plastic Container | United States | 10GM/100ML | injectable | Marketed | Otsuka Icu Medcl |
| Dextrose 5% and Lactated Ringer'SCombination | United States | 20MG/100ML; 5GM/100ML; 30MG/100ML; 600MG/100ML; 310MG/100ML | injectable | Marketed | Fresenius Kabi USA |
| Dextrose 50% in Plastic Container | United States | 50GM/100ML, 50GM/100ML | injectable | Marketed | Otsuka Icu Medcl |
| Dextrose 70% in Plastic Container | United States | 70GM/100ML, 70GM/100ML | injectable | Marketed | Otsuka Icu Medcl |
| Dextrose 5% and Sodium Chloride 0.9%Combination | United States | 5GM/100ML; 900MG/100ML | injectable | Marketed | Fresenius Kabi USA |
| Dextrose 5% and Sodium Chloride 0.45%Combination | United States | 5GM/100ML; 450MG/100ML | injectable | Marketed | Fresenius Kabi USA |
| Dextrose 5% and Sodium Chloride 0.225%Combination | United States | 5GM/100ML; 225MG/100ML | injectable | Marketed | Fresenius Kabi USA |
| Dextrose 5% | Saudi Arabia | Authorised | Pharmaceutical Solution Industries (PSI) | ||
| Dextrose 5% | Saudi Arabia | Authorised | Pharmaceutical Solution Industries (PSI) | ||
| Dextrose 5% | Saudi Arabia | Authorised | McGAW | ||
| Dextrose 5% | Saudi Arabia | Authorised | McGAW | ||
| Dextrose 5% | Saudi Arabia | Authorised | Pfrimmer | ||
| Dextrose 5% | Saudi Arabia | Authorised | Pharmaceutical Solution Industries (PSI) | ||
| Dextrose 5% | Saudi Arabia | Authorised | McGAW | ||
| Dextrose 5% | Saudi Arabia | Authorised | Pfrimmer | ||
| Dextrose 5% | Saudi Arabia | Authorised | Pharmaceutical Solution Industries (PSI) | ||
| Dextrose 5% | Saudi Arabia | Authorised | Pharmaceutical Solution Industries (PSI) |
